$51.95
$-1.57 (-3.02%)
End-of-day quote: 05/16/2024
NasdaqCM:EXAS
Exact Sciences Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ROG | Roche Holding | SWX | Hold | CHF237.10 | CHF307.83 | 0.00% | 9 | CHF191.28B |
| NOVN | Novartis | SWX | Hold | CHF93.37 | CHF105.00 | 0.00% | 9 | CHF190.51B |
| A | Agilent Technologies | NYSE | Outperform | $154.23 | $138.82 | 0.00% | 10 | $45.20B |
| ILMN | Illumina | NasdaqGS | Outperform | $111.07 | $159.28 | 0.00% | 9 | $18.23B |
| LH | Laboratory Corp of America Hol... | NYSE | Outperform | $210.59 | $241.28 | 0.00% | 9 | $17.97B |
| HOLX | Hologic | NasdaqGS | Outperform | $75.02 | $81.06 | 0.00% | 3 | $17.49B |
| DGX | Quest Diagnostics | NYSE | Outperform | $144.34 | $141.17 | 0.00% | 8 | $15.38B |
| ERF | Eurofins Scientific | ENXTPA | Hold | 58.26€ | 0.00€ | 0.00% | 5 | 11.05€B |
| NTRA | Natera | NasdaqGS | Buy | $106.46 | $74.41 | 0.00% | 8 | $11.68B |
| QGEN | QIAGEN N.V. | NYSE | Outperform | $45.69 | $0.00 | 0.00% | 3 | $9.67B |
| SHL | Sonic Healthcare | ASX | Hold | $26.63 | $34.12 | 0.00% | 0 | $12.78B |
| BIO | Bio-Rad Laboratories Inc | NYSE | Outperform | $293.85 | $536.80 | 0.00% | 1 | $7.92B |
| TXG | 10x Genomics | NasdaqGS | Outperform | $25.01 | $58.14 | 0.00% | 2 | $3.16B |
| TWST | Twist Bioscience | NasdaqGS | Outperform | $47.01 | $34.00 | 0.00% | 2 | $2.40B |
| GH | Guardant Health | NasdaqGS | Buy | $25.36 | $43.00 | 0.00% | 2 | $2.37B |
| NEO | NeoGenomics | NasdaqCM | Outperform | $14.80 | $20.09 | 0.00% | 9 | $1.95B |
| SDGR | Schrödinger | NasdaqGS | Outperform | $22.76 | $44.22 | 0.00% | 1 | $1.84B |
| MYGN | Myriad Genetics | NasdaqGS | Outperform | $25.29 | $22.08 | 0.00% | 8 | $1.79B |
| VCYT | Veracyte | NasdaqGM | Outperform | $22.88 | $32.17 | 0.00% | 4 | $1.61B |
| OPK | OPKO Health | NasdaqGS | Outperform | $1.01 | $6.70 | 0.00% | 0 | $1.18B |
| LAB | Standard BioTools | NasdaqGS | Buy | $2.57 | $4.00 | 0.00% | 1 | $856.71M |
| CYRX | Cryoport | NasdaqCM | Outperform | $12.65 | $17.61 | 0.00% | 3 | $806.30M |
| FLGT | Fulgent Genetics | NasdaqGM | Hold | $22.11 | $31.50 | 0.00% | 2 | $642.86M |
| CDNA | CareDx, Inc | NasdaqGM | Outperform | $15.50 | $11.80 | 0.00% | 1 | $575.21M |
| VNET | VNET Group | NasdaqGS | Outperform | $2.05 | $33.17 | 0.00% | 0 | $531.69M |
| ADPT | Adaptive Biotechnologies | NasdaqGS | Outperform | $3.61 | $8.67 | 0.00% | 2 | $515.79M |
| CRDF | Cardiff Oncology | NasdaqCM | Buy | $3.63 | $8.37 | 0.00% | 1 | $154.70M |
| PSNL | Personalis | NasdaqGM | Outperform | $1.40 | $4.45 | 0.00% | 3 | $80.14M |
| AGL | ANGLE | AIM | Buy | £0.21 | £0.97 | 0.00% | 0 | £46.23M |
| MAP | Microba Life Sciences | ASX | Buy | $0.20 | $0.44 | 0.00% | 1 | $76.13M |
| OCX | OncoCyte | NasdaqCM | Outperform | $2.93 | $3.90 | 0.00% | 0 | $39.16M |
| CNTG | Centogene N.V. | NasdaqGM | Outperform | $0.37 | $1.37 | 0.00% | 0 | $23.96M |
| DMTK | DermTech | NasdaqCM | Outperform | $0.50 | $3.60 | 0.00% | 4 | $17.29M |
| TCRT | Alaunos Therapeutics | NasdaqCM | Hold | $1.16 | $1.37 | 0.00% | 3 | $20.58M |
| FRES | Fresh2 Group | NasdaqCM | - | $0.39 | $0.00 | 0.00% | 0 | $20.50M |
| AXDX | Accelerate Diagnostics | NasdaqCM | Buy | $0.88 | $5.00 | 0.00% | 1 | $19.07M |
| NSTG | NanoString Technologies | NasdaqGM | - | $0.12 | $5.02 | 0.00% | 4 | $6.98M |
| NVTA | Invitae | NYSE | - | $0.00 | $0.71 | 0.00% | 8 | $3.18M |
| ECX | Epigenomics | XTRA | Outperform | 1.70€ | 52.65€ | 0.00% | 1 | 1.50€M |
| MOTS | Motus GI Holdings | NasdaqCM | - | $0.11 | $8.30 | 0.00% | 2 | $0.55M |
| BIOC.Q | Biocept | OTCPK | Hold | $0.00 | $8.00 | 0.00% | 0 | $0.13M |
| MTST | MetaStat | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
| HTGM.Q | HTG Molecular Diagnostics | OTCPK | - | $0.00 | $6.00 | 0.00% | 1 | $0.00M |
